Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Could well be Mennen buying more I suppose?
ANY ONE KNOW WHY THE BUYING INTEREST TODAY - ALREADY 78 TRADES?
Buys getting listed as sells now
15 may
20 may
13 June.
Last 3 RNs. Memen medical loading up. More to come more likely.
I thought that was yesterday or are they buying more?
Another buy from Mennen Medical, now up to 6%.
It is part of Redworth Capital Group
Redworth Capital is a multinational investment house with offices in Philadelphia (USA), Tel Aviv (ISR) and London (UK), engaged in diversified business segments: Medical Devices and Technologies, Real Estate and Entertainment
This is great news. Board have finally realised its time for a change..
Board have removed Neil Campbell from CEO position and replaced him with Roy Davis, who becomes NE Chairman and Interim CEO. The company will update Shareholders about search for permanent CEO.
As a reminder when Davis joined NEDs in December his resume had the following information:
"Roy brings a wealth of commercial experience in medical devices companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. He has held leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualisation, until its acquisition by Olympus Corporation in 2008 for $1.9 billion."
He gives me hope that he can grab IHC by the scruff of the neck. Make the necessary changes and get the company delivering some profit and value to shareholders
I don't know something that anyone else should be aware of but what I do know is that if this company had been efficiently run then it would never have got into a situation where it's not recovering a large debt. Was the debt not insured because it would have been sensible to have done this. This is all quite basic stuff and it's completely pointless to make a sale if there's a chance that you won't be paid for it.
But a cash call might do the trick?
2reincarnated. The revenue was £41.23m for y/e 31 Jan 23. The expected revenue is £37m for y/e 31 Jan 24. Y/e 31 Jan 23 was profitable, just. I am not sure why we should be worried at the moment about the company going into administration, although clearly we will need to see the full figures for y/e 31 Jan 2024 before we can be certain either way. Do you know something that the rest of us should be aware of?
Takeover target yes correct!
But only by the administrators.
The individuals running this business are obviously completely out of their depth and need to sell the company ASAP. I'm going to use the abbreviation WTU, meaning worse than useless. The alternative is that the company goes bust which shouldn't be allowed to happen and won't happen as long as the dead wood is cleared out.
First time I have seen this Company, but looking at their product ranges, have taken a small plunge. Looks like an over reaction regarding the sell-off.
Been in this since Inditherm days. Still believe in the product potentials. Missed out on an exit in the past when it was briefly around 150p but still think it's fundamentally good. Topped up this morning
Got to be a takeover target at this level?
Ludicrous over reaction on opening, down 45%.
The update is just a re-hash of January's update. The bank waiver has been extended for another year.
Yes, need to material export order to be fulfilled, but mid single digit growth and US business started positively.
Okay work to be done as results H2 loaded.
Got to be a takeover target if this management team can't fix a company with mainly non discretionary healthcare spend, surely?
The trading update is a bit of a mixed bag. Potential for the expected major order to fail to materialise is disappointing but (single digit) growth without that order, and decent performance in Florida, are both mildly encouraging. Hopefully the market reaction will not be too harsh, especially given that the share price is already pretty “bombed out”.
This company does seem to be utterly useless / hopeless and it would be nice to think that it could be sold ASAP because the current lot of directors obviously haven't got a clue as to how to run a business. Anyone in agreement?
I guess shortfall is around 10%. FY to end Jan 23 was rev £41.2m, FY to end Jan 22 was £41.4m
Today FY to end Jan 24 is £37.0m
Agreed, ragnarlothbrok. It would have been so simple to state what the size of the shortfall is.
Awful…. Bad news, lack of clarity is striking. It’s going to sting today. I reckon back down to low 40s. Capital raising probably now required, heavily discounted of course
Not the best trading update...
Not seen any tips, they do have results due soon (released mid Feb last year) and given they submitted for Fda approval for the SLE6000 ventilator almost 6 months ago expecting an update on that fairly soon too. I think it was oversold and was overdue a rerate anyway
Hello, upward movement in the shares today suggests maybe a tip - any thoughts as too the source?
RNS out today - IHC buy Airon Corp for $2.5m ($1.5m from cash reserves and $1.0m to be paid at later date based on delivery of future revenues) Only a small outfit with revenue $1.4m, loss $0.4m, net assets $1.3m) however it will be a good platform to sell the SLE6000 neo natal ventillator, subject to FDA approval.
Looks a good acquisition to increase sales in large US market.